GS[removed]A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF ADEFOVIR DIPIVOXIL WHEN GIVEN IN COMBINATION WITH HAART FOR THE TREATMENT OF HIV-INFECTED PATIENTS WHO HAVE FAILED THEIR FIRST HAART REGIMEN

First Page		Document Content
Date: 2012-06-28 04:30:05 Pharmacology Medicine Organofluorides Health Microbicides Tenofovir/emtricitabine Tenofovir Emtricitabine/tenofovir/efavirenz Emtricitabine Gilead Sciences Fixed dose combination HIV/AIDS		GS[removed]A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF ADEFOVIR DIPIVOXIL WHEN GIVEN IN COMBINATION WITH HAART FOR THE TREATMENT OF HIV-INFECTED PATIENTS WHO HAVE FAILED THEIR FIRST HAART REGIMEN Add to Reading List Source URL: www.wipo.int Download Document from Source Website File Size: 377,08 KB Share Document on Facebook

	KEI request for investigation into anticompetitive aspects of Gilead Voluntary Licenses for patents on Tenofivir and Emtricitabine 12 February 2007 Federal Trade Commission Washington, DC Attn: Randy Marks DocID: 1umkN - View Document
	AIDS InfoNetwww.aidsinfonet.org Fact Sheet Number 478 Biktarvy (bictegravir + emtricitabine + tenofovir alafenamide) DocID: 1ucKl - View Document
	Pre-Exposure Prophylaxis (PrEP): A primer for primary care providers Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injection DocID: 1rPaA - View Document
	PrEPARING FOR THE END OF HIV? How to access PrEP in Contra Costa County… For Insured Folks: Private Medical Provider-Most health insurance companies cover Truvada (emtricitabine and tenofovir disoproxil fumarate, the m DocID: 1rAVd - View Document
	Trans and Gender Non-Conforming (TGNC) Folks and PrEP: WHAT WE SHOULD KNOW DocID: 1reG7 - View Document